With a projected 12–15% CAGR through 2028 due to post-pandemic wellness demand, growing e-commerce distribution, and growing health consciousness, India's nutraceutical and herbal medicine market is booming. Manufacturers in Jammu, such as Phytochem Remedies, are increasing production with ISO-certified facilities and unrealised growth potential. To capitalise on this momentum, Phytochem Remedies India Private Limited is launching an SME IPO on December 18, 2025.
Phytochem Remedies IPO Details:
Issue Management:
Mefcom Capital Markets Ltd. serves as the sole book-running lead manager for the Phytochem Remedies (India) IPO, overseeing underwriting, compliance, and distribution.
Registrar Details:
Bigshare Services Pvt. Ltd. handles allotment, refunds, and demat credits—contact them at +91-22-6263 8200 or their portal for status checks.
Phytochem Remedies IPO Allotment Status:
To check your IPO allotment status:
Visit the Bigshare Services Pvt. Ltd. IPO Application Status page.
Select the company name from the dropdown menu.
Select and enter PAN, Application Number, DP/Client ID, or Account Number/IFSC.
Click Submit to view your allotment status.
Note: 50% of shares will be unlocked 30 days after allotment, while the rest will be free from lock-in restrictions after 90 days.
Action Links:
Open Demat Account: Get started with demat here
Subscription Update: Check live subscription here
GMP Update: Check current grey market premium here
Phytochem Remedies (India) Limited produces superior corrugated packing goods. The company was founded in 2002, started producing in 2014, and currently has two facilities in Bari Brahmana, Jammu, offering substantial growth potential and logistical advantages. The company's expansion and modernisation have been guided by the leadership of Niranjan Surana, Shilpa Surana, Aditi Bohra, and Bohra Agrifilms Private Limited. Phytochem specialises in corrugated boxes, rolls, sheets, and pads made to satisfy industry-specific specifications. It provides supplies to the automotive, FMCG, agricultural, pharmaceutical, and pesticide industries. A semi-automated line and a fully automated corrugated board mill that was put into service in 2022 are among its production capabilities.
The company has a manufacturing-to-order business strategy and makes money by offering customised, durable, and affordable packaging solutions. Given the increasing need for packaging solutions across industries, Phytochem is well-positioned to take use of its operational skills and facilities that are ready for development in order to support future growth.
Phytochem Remedies (India)'s promoters hold a 100% pre-IPO stake, diluting to 66.88% post-issue.
Phytochem Remedies IPO proceeds will be deployed towards the following objectives:
Phytochem Remedies SME IPO skips anchor investors entirely, opening December 18 with a fixed-price structure allocating 47.48% to NII and retail each, plus 5% to market makers— no QIB portion.
Implications: This SME-typical setup signals reliance on HNI/retail momentum over institutional validation, potentially amplifying volatility but suiting the low ₹22.48 Cr issue size. GMP trends (check live) will gauge early sentiment pre-subscription.
Investor Takeaway: Absence of anchors keeps liquidity focused on post-listing; monitor NII bidding strength against packaging peers like Perfectpac for subscription cues.
Quick Ratios: PAT margins ~15%, Debt/Equity ~1.14x (Sep '25), steady asset growth 45% YoY.
The important risks and strengths of the Phytochem Remedies IPO are mentioned below:
Strengths
Built long-term ties with customers to ensure steady sources of income.
Consistent financial growth combined with a proven operational track record.
This contemporary Jammu facility has an automatic corrugated factory for 2022, an emphasis on sustainability, and area that is available for growth.
A diverse custom packaging portfolio that serves the FMCG, pharmaceutical, automotive, and food sectors.
Experienced promoters leading the way in regional markets.
Risks
Revenue concentration from top clients leads to dependency vulnerability.
Risk of raw material supply in the absence of long-term vendor agreements.
Manufacturing in Jammu in only one location makes it vulnerable to regional problems.
Concerns about payment delays are increased by high trade receivables.
Potential working capital challenges are indicated by past negative cash flows.
Phytochem Remedies (India) is a Jammu-based corrugated packaging manufacturer that specialises in customised boxes for the FMCG, pharmaceutical, and automotive industries. It runs contemporary ISO-certified facilities with untapped expansion potential in response to consistent industry demand. Investors may assess customer concentration risks, debt reduction strategies, and peer valuation multiples in relation to the FY25 PAT growth of 454% within the packaging sector.
Action Links:
Open Demat Account: Get started with demat here
Subscription Update: Check live subscription here
GMP Update: Check current grey market premium here
1. What is the issue size and price of the Phytochem Remedies IPO?
39 lakh fresh shares at a fixed ₹98/share (₹38.22 Cr total), minimum lot 1,200 shares (₹1.18 lakh).
2. When does bidding open for the Phytochem Remedies IPO?
December 18-22, 2025; allotment Dec 23; lists BSE SME Dec 26.
3. Who manages the Phytochem Remedies issue?
Lead manager: Mefcom Capital; Registrar: Bigshare Services (+91-22-6263 8200).
4. What are the key financials of the Phytochem Remedies IPO?
FY25 revenue ₹36.81 Cr (+12% YoY), PAT ₹4.48 Cr, EBITDA ₹8.69 Cr (23% margin), debt ₹18.69 Cr.
5. How will Phytochem Remedies IPO proceeds be used?
Machinery (₹13.6 Cr), construction (₹5.9 Cr), debt repayment (₹9.4 Cr), general purposes.
6. What are the investor quotas?
RII/NII 47.5% each, Market Maker 5% (no QIB/anchor).
7. Who are the Phytochem Remedies listed peers?
Perfectpac (P/E 18x), Worth Peripherals (14x); company valued at 6.9x P/E.
